KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Comstock Resources (CRK) Cash & Equivalents (2016 - 2026)

Comstock Resources has reported Cash & Equivalents over the past 17 years, most recently at $23.9 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 251.96% year-over-year to $23.9 million; the TTM value through Dec 2025 reached $23.9 million, up 251.96%, while the annual FY2025 figure was $23.9 million, 251.96% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $23.9 million at Comstock Resources, up from $19.2 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $77.4 million in Q1 2021 and troughed at $6.4 million in Q1 2024.
  • A 5-year average of $26.1 million and a median of $21.9 million in 2023 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: crashed 84.33% in 2022 and later soared 412.07% in 2025.
  • Year by year, Cash & Equivalents stood at $30.7 million in 2021, then surged by 78.23% to $54.7 million in 2022, then crashed by 69.5% to $16.7 million in 2023, then plummeted by 59.21% to $6.8 million in 2024, then skyrocketed by 251.96% to $23.9 million in 2025.
  • Business Quant data shows Cash & Equivalents for CRK at $23.9 million in Q4 2025, $19.2 million in Q3 2025, and $25.9 million in Q2 2025.